LEXINGTON, Mass.--(BUSINESS WIRE)--Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the Company will be presenting at the 13th Annual BIO CEO & Investor Conference at 4:00 p.m. EST on February 14, 2011, in New York City.
